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A B S T R A C T
To determine in acute myocardial infarction with an ST elevation (STEMI) treated with fibrinolytics frequency of
ventricular premature beats (VPBs) and ventricular tachycardia (VT) according to the damaged area and residual car-
diac function. With anterolateral infarction with ejection fraction (EF)<45%, incidence of VPBs<10/h was statistically
significantly reduced (p<0.001) while incidence of VPBs10/h as well as VPBs in a pair and VT was increased (p<
0.001). With anteroseptal infarction with EF<45%, incidence of VPBs<10/h was statistically reduced (p=0.06) and inci-
dence of VPBs>10/h, VPBs in a pair and VT was increased (p=0.06). With inferior and inferoposterior infarction with
EF<45%, incidence of VPBs<10/h was reduced and incidence of VPBs10/h, VPBs in a pair and VT was increased.
However, such difference was not statistically significant. Along with reduced residual cardiac function, one can also ex-
pect increase in frequency of VPBs and VT in all forms of STEMI regardless the area of damage. Such frequency is sig-
nificant with all forms of anterior infarction, that is to say, slightly more with anterolateral infarction in relation to
anteroseptal one. However, with inferior and inferoposterior infarction this frequency of VPBs i VT is not significant.
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Introduction
Ventricular premature beats (VPBs) is among the
most common arrhythmias and it affects patients with
and without heart disease. In people who do not suffer
from heart disease, incidence of VPBs is not connected
with increased morbidity or mortality1. VPBs and ven-
tricular tachycardia (VT) can be caused by the well-
known mechanism: increased automatism, re-entry and
trigger activity2,3. That is the most frequent and almost
always present form of arrhythmias in patients suffering
from acute myocardial infarction (AMI)4. As a conse-
quence of infarction, there are in myocardium non-ho-
mogeneous areas of necrosis which surround the islets of
still viable myocardium. Due to weak connection among
these islets, which still have normal electrophysiological
qualities, one can expect heterogeneous speed of imple-
mentation and duration of refractoriness which is the basic
element of circular arrhythmias. It is considered today
that VPBs and VT do not have a long-term prognostic
importance if they occur in the course of 24–72 hours af-
ter discomfort has begun. Thus today, routinely prophy-
lactic antiarrhythmic treatment is not recommended ex-
cept in case of stable or symptomatic arrhythmias5,6. The
arrhythmias which occur after this period of time have a
tendency of later recurrence and thus worse prognosis,
and they refer to more serious damage of ventricles and
they are connected with increased mortality7–9. Resear-
ches show that, while frequent complex ventricular ecto-
pia is an independent risk factor, damaged ventricular
function is a significantly bigger risk factor10,11. While in
the past, frequent multifocal or early diastolic extrasys-
toles were routinely treated, today pharmacotherapy is
meant only for the patients suffering from stable or
symptomatic arrhythmias. Today in the era of invasive
cardiology, there are also not enough clear data about the
influence of reduced blood flow in coronary arteries upon
the incidence of such arrhythmias12–14. Higher incidence
of VPBs and VT with a segmental incident of contracility
in the course of post-infarction period was discovered by
Siogas et al. but with increased arterial blood pressure15.
Although the highest incidence of VPBs and VT is during
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the first hours of AMI16, due to higher prognostic impor-
tance of later arrhythmias17, the period after seven days
of hospitalization was analyzed in this study.
The aim of this study is to re-evaluate, in patients suf-
fering from AMI with an ST elevation (STEMI), fre-
quency of significant VPBs and VT regarding the dam-
aged area and residual cardiac function after the first
week of hospitalization.
Patients and Methods
This research was carried out in the Department of
Cardiology of the General hospital in Karlovac (Croatia)
between 1999 and 2005. This study included only the pa-
tients suffering from the first STEMI who were hospital-
ized within six hours after the pain had started. All the
patients were exposed to a fibrinolytic treatment with
streptokinase and in the period between the seventh and
the tenth day of their hospitalization they were exposed
to a 24-hour ECG (Holter) monitoring. In total 172 pa-
tients, 129 men and 43 women between the age of 42 and
76, with the average age 61, were studied. Ejection frac-
tion (EF) of the left ventricle 45% was present among
114 patients and EF<45% among 58 patients. 29 pa-
tients suffered from anterolateral infarction, 51 patients
suffered from anteroseptal infarction, 44 patients suf-
fered from inferior infarction and 48 patients suffered
from inferoposterior infarction. By means of Holter mo-
nitoring subjects with insignificant number of VPBs
(<10/h) were verified in contrast with those subjects
with significant VPBs (10/h or in a pair) and VT. Three
or more consecutive VPBs were considered for VT. Pa-
tients with significant artefacts during Holter monitor-
ing were excluded from the study. The patients were
compared according to residual cardiac function (EF)
which was determined by means of an ultrasound of the
heart which was carried out in the period from the sev-
enth until the tenth day of their hospitalization. Mea-
surement of EF of left ventricle was carried out by an ul-
trasound (ALOKA-ProSound SSD 5500) in M-mode
according to Teichholz's method. The control study in-
cluded patients with EF45% and the case study in-
cluded the patients with EF<45%. According to the re-
gional damage of myocardium, patients suffering from
anterolateral and anteroseptal infarction as areas for
which the artery LAD (left anterior descending) and a
greater part of the artery Cx (circumphlex artery) are re-
sponsible, were included in the study. The study also in-
cluded the patients suffering from inferior and infero-
posterior STEMI for which RCA (right coronary artery)
and a lesser part of Cx are responsible. ECG criterium for
acute anterolateral STEMI was ST elevation in leads
V4–V6, for anteroseptal it was in leads V1–V3, for infe-
rior in leads II, III aVF and for acute inferoposterior
STEMI in leads II, III, aVF and ST depression and in-
crease R wave amplitude in leads V1–V3. All types of in-
farction which did not completely satisfy these criteria or
had criteria for other localizations (e.g. posterior, lateral,
large anterior) were excluded from the study. The study
included only those patients who did not have any other
possible reasons for VPBs and VT such as hyperkalemia,
hyperthyroidism, hypertrophy of the left ventricle, pro-
lapse of mitral valve, febrility, therapy by digitalis and
bronchodilatators as well as positive earlier anamnesis of
VPBs and VT. Patients with chronic heart failure were
also not included in the study. All the patients were
treated with ß-blockers as the only antiarrhythmic drug,
with acetylsalicylic acid (ASA), ACE-inhibitors and with
statins. While testing, the test of proportions and Chi-
square analysis with the level of reliability of 99% were
used.
Results
With acute anterolateral STEMI with EF<45%, inci-
dence of VPBs<10/h was statistically significantly re-
duced (p=0.001). However, incidence of VPBs10/h, VPBs
in a pair and VT was increased (p<0.001).
With acute anteroseptal STEMI with EF<45%, inci-
dence of VPBs<10/h was reduced (p=0.06), while inci-
dence of VPBs10/h, VPBs in a pair and VT was in-
creased (p=0.06).
With acute inferior STEMI with EF<45%, incidence
of VPBs<10/h was reduced but incidence of VPBs10/h,
VPBs in a pair and VT was increased. However, such
probability of occurrence was not statistically significant.
With acute inferoposterior STEMI with EF<45%, in-
cidence of VPBs<10/h was reduced, but incidence of







N % N %
<10/h 21 91 3 50 2.38 (<0.001)
>10/h, in
a pair, VT
2 9 3 50 2.38 (<0.001)
Total 23 100 6 100
STEMI – myocardial infarction with an ST elevation, EF – ejec-







N % N %
<10/h 31 84 9 64 1.51 (0.06)
>10/h, in
a pair, VT
6 16 5 36 1.52 (0.06)
Total 37 100 14 100
STEMI – myocardial infarction with an ST elevation, EF – ejec-
tion fraction, VPBs – ventricular premature beats, VT – ventric-
ular tachycardia
VPBs10/h, VPBs in pair and VT was increased. How-
ever, such probability of occurrence was not statistically
significant.
Discussion
The research into the incidence of VPBs and VT in
acute anterolateral, anteroseptal, inferior and infero-
posterior STEMI was inspired by the notion that most
researches into post-infarctions ventricular arrhythmias
analyze their incidence according to only two damaged
areas, anterior and inferior ones18,19.
In this research, with acute anterolateral STEMI (Ta-
ble 1) due to reduced EF<45%, incidence of VPBs<10/h
statistically significantly decreased (p<0.001) while inci-
dence of VPBs10/h, VPBs in a pair and VT increased
(p<0.001). These data are in accordance with some other
studies in which, according to Efre, ventricular arrhyth-
mias more often occur in anterior infarction20. Also, Hui-
kuri et al.21 and Moss et al.22 point out that reduced EF
<35% causes significant increase in frequency of ventric-
ular arrhythmias.
With acute anteroseptal STEMI (Table 2) due to re-
duced EF<45%, incidence of VPBs<10/h statistically sig-
nificantly decreased, but at the level p=0.06 which is in
accordance with the increase in incidence of VPBs 10/h,
VPBs in a pair and VT (p=0.06). This indicates that even
with anterior infarctions there are slight differences in
significance of post-infarction VPBs incidence. Possibly
this is so, because the anteroseptal area is irrigated
mainly by LAD while the anterolateral area, besides
LAD, is also irrigated by Cx. This causes necrosis which
affects larger areas of myocardium and this is in accor-
dance with some other author's data which say that dam-
aged ventricular function also increases possibility of
ventricular arrhythmias10,11.
With acute inferior STEMI (Table 3) and inferopos-
terior STEMI (Table 4), there was no statistically signifi-
cant difference between the incidence of VPBs and VT
due to reduced EF <45%. Similar results about less fre-
quent ventricular arrhythmias in inferior infarction in
relation to anterior one were also obtained by Bluzaite et
al.18 and Stone et al.19. The difference is the fact that
more frequent atrial arrhythmias occur in inferior in-
farction due to damage of sinoatrial node which is irri-
gated via RCA branch20.
The weakness of this study is, due to simplicity of
measurement of ejection fraction of left ventricle, the us-
age of Teichholz´s method in M-mode. More accurate es-
timate of hypokinetic areas would be obtained by mea-
surement in 2 D-mode.
To conclude, along with reduced residual cardiac
function in post-infarction period, one can also expect in-
crease in frequency of VPBs and VT incidence in all
forms of STEMI regardless the area of damage. Such fre-
quency is statistically significant only in both forms of
anterior infarction. It is a bit more significant in antero-
lateral infarction in relation to anteroseptal one. How-
ever, there is no statistically significant increase in fre-
quency of VPBs and VT in inferior and inferoposterior
infarction. This notion can help us anticipate in advance
the danger of more frequent incidence of VPBs and VT in
STEMI with regard to the area of damage.
R E F E R E N C E S
1. ARONOW WS, Am J Noninvas Cardiol, 5 (1991) 88. — 2. BREIT-
HARD G, BORGGREFE M, MARTINEZ-RUBIO A, BUDDE T, Eur
Heart J (suppl E), 10 (1989) 9. — 3. LOH P, DE BAKKER JMT, HOCINI
M, THIBAULT B, HAUER RNW, JANSE MJ, Circulation, 100 (1999)
1346. — 4. ANTMAN EM, BRAUNWALD E, Heart Disease (Saunders,
Philadelphia, 2001). — 5. MILLER JM, ZIPES DP, Heart Disease (Saun-
ders, Philadelphia, 2001). — 6. UREK R, CUBRILO-TUREK M, CRNCE-
VIC-UREK M, Coll Antropol, 25(1) (2001) 279. — 7. DROGEMÜLLER A,
SEIDL K, SCHIELE R, SCHNEIDER S, GITT A, GOTTWIK M, VON
LEITNER ER, POPPE C, RETTING-STURMER G, SENGES J, Z. Kar-
diol, 92 (2) (2003) 164. — 8. SARTER BH, FINKLE JK, GERSZTEN RE,
BUXTON AE, J Am Coll Cardiol, 28 (1996) 122. — 9. CHEEMA AN,
SHEU K, PARKER M, KADISH AH, GOLDBERGER JJ, Circulation, 98
(19) (1998) 2030. — 10. KLEIN H, AURICCHIO A, REEK S, GELLER C,
Am J Cardiol, 83 (1999) 91D. — 11. BUXTON AE, LEE KL, FISHER JD,
JOSEPHSON ME, PRYSTOWSKY EN, HAFLEY G, N Engl J Med, 341
(1999) 1882. — 12. HOHNLOSER SH, KLINGENHEBEN T, ZABEL M,
SCHÕPPERL M, MAUSS O, J Am Coll Cardiol, 33 (1999) 1895. — 13.
CALLANS DJ, SEGAL BL, Geriatrics, 51 (1) (1996) 33-6. — 14. PAGA-
NELLI F, BARNAY P, IMBERT-JOSCHT I, GELISSE R, SAADJIAN A,
MUNDLE O, LE’VY S, European Heart Journal, 22 (2001) 1931. — 15.
SIOGAS K, PAPPAS S, GRAEKAS G, GOUDEVENOS J, LIAPI G, SIDE-







N % N %
<10/h 28 76 5 71 0.24 (n.s.)
10/h, in
a pair, VT
9 24 2 29 0.23 (n.s.)
Total 37 100 7 100
STEMI – myocardial infarction with an ST elevation, EF – ejec-







N % N %
<10/h 36 86 4 67 1.71 (n.s.)
10/h, in
a pair, VT
6 14 2 33 1.72 (n.s.)
Total 42 100 6 100
STEMI – myocardial infarction with an ST elevation, EF – ejec-
tion fraction, VPBs – ventricular premature beats, VT – ventric-
ular tachycardia
RIS DA, Heart, 79 (1998) 268. — 16. JUG M, BATINIC Z, GOLDNER V,
DELIMAR N, Lije~ Vjesn, 117 (1995) 68. — 17. PULJEVIC D, BULJEVIC
B, MILICIC D, Lije~ Vjesn, 123 (2001) 191. — 18. BLUZAITE I, BRAZ-
DZIONYTE J, BLUZHAS J, MICKEVICIENE A, JHong Kong Coll Car-
diol, 5 (1997) 119. — 19. STONE PH, RAABE DS, JAFFE AS, GUSTAF-
SON N, MÜLLER JE, TURI ZG, RUTHERFORD JD, PASSAMANI E,
WILLERSON JT, SOBEL BE, ROBERTSON T, BRAUNWALD E, J Am
Coll Cardiol, 11 (1988) 453. — 20. EFRE AJ, Gender Bias in Acute Myo-
cardial Infarction (Williams & Wilkins, Lippincott, 2004). — 21. HUIKU-
RI HV, CASTELLANOS A, MYERBURG RJ, N Engl J Med., 345 (20)
(2001) 1473. — 22. MOSS A.J, HALL WJ, CANNOM DS, DAUBERT JP,
HIGGINS SL, KLEIN H, LEVINE JH, SAKSENA S, WALDO AL, WIL-
BER D, BROWN MW, HEO M, N Engl J Med, 335 (1996) 2933.
D. Horvat
Department of Internal Diseases, General Hospital Karlovac, 3 Andrija [tampar, 47000 Karlovac, Croatia
e-mail: davor.horvat@ka.t-com.hr
U^ESTALOST VENTRIKULSKE EKSTRASISTOLIJE I VENTRIKULSKE TAHIKARDIJE
U STEMI-u TRETIRANOM FIBRINOLITICIMA
S A @ E T A K
Odrediti u akutnom infarktu miokarda sa ST elevacijom (STEMI) tretiranom sa fibrinoliticima u~estalost ventri-
kulskih ekstrasistola (VES) i ventrikulske tahikardije (VT) prema zahva}enoj regiji i rezidualnoj kardijalnoj funkciji. U
anterolateralnom infarktu kod ejekcijske frakcije (EF)<45% statisti~ki zna~ajno se smanjuje incidencija VES<10/h
(p<0,001), a pove}ava incidencija VES10/h, VES u paru i VT (p<0,001). U anteroseptalnom infarktu kod EF<45%
statisti~ki se smanjuje incidencija VES<10/h (p=0,06), a pove}ava incidencija VES10/h, VES u paru i VT (p=0,06). U
inferiornom i inferoposteriornom infarktu kod EF<45% smanjuje se incidencija VES<10/h, a pove}ava incidencija VES
10/h, VES u paru i VT, no ta razlika nije statisti~ki zna~ajna. Smanjenjem rezidualne kardijalne funkcije pove}ava se
u~estalost VES i VT u svim oblicima STEMI-a bez obzira na regiju o{te}enja. Ta je u~estalost zna~ajna kod oba oblika
anteriornog infarkta i to ne{to vi{e kod anterolateralnog u odnosu na anteroseptalni infarkt, dok kod inferiornog i
inferoposteriornog infarkta u~estalost pojavljivanja VES i VT nije zna~ajna.
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